Researchers have shown that placing individual metal atoms on carefully chosen supports can dramatically sharpen the ...

A new study reports that a biochar-enhanced photocatalyst can efficiently degrade antibiotic contaminants in water, offering a promising strategy for ...

“As DRAM technology nodes move into the sub-10 nm regime, capacitor scaling is increasingly constrained by both footprint loss and a hard physical thickness limit for the entire ...

Astronomers have produced the most detailed map yet of dark matter, revealing the invisible framework that shaped the Universe long before stars and galaxies formed. Using powerful new observations ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. After the ...

Running I test running shoes, and if you need a cushioned sneaker for marathon training, the Nike Vomero Plus is my top pick — here’s why Running I ran 35 miles in the Puma MagMax Nitro 2 — here's my ...

In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...

Anchor your business to a stubborn, real-world problem customers cannot ignore. Replace hustle with systems that standardize decisions, data flow and accountability. Ambition isn’t what holds ...

Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...

First, there was the Pegasus. Nike’s neutral everyday trainer has run circles around the competition for literal decades. According to Strava, it remains the most popular shoe across the platform, ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Structure Therapeutics ...